Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole Duration for GI Injury Prevention in CABG Patients on DAPT
NCT03038009Phase 4Withdrawn
- Sponsor
- Ruijin Hospital
- Start
- Oct 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pantoprazole in gastroduodenal mucosal injury, gastric ulcer, sponsored by Ruijin Hospital. Planned start Oct 2018; status: withdrawn.
02
Drugs
pantoprazole
03
Conditions
gastroduodenal mucosal injurygastric ulcer
Beyond the preview
Go deeper on NCT03038009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038009.